Furthermore, increased expression of IL-1 has been linked to SS-associated keratinizing squamous metaplasia of the ocular mucosal epithelium [37,38], indicating that IL-1R targeted treatment may be beneficial for treating SS-associated ocular surface illness, including dry eye [32]. Here, IL1R1 is linked to synovial sarcoma.